HYBRID CONCEPTS INTERNATIONAL
"HYBRID CONCEPTS INTERNATIONAL" is a word and design mark owned by Hybrid Concepts International, LLC, filed at the USPTO on December 10, 2021. It is registered and covers classes 35, 36, 42 and 44.
- Status
- Registered
- Since March 28, 2023
- Filed
- December 10, 2021
- Registered
- March 28, 2023
- Expires
- Not recorded
- Application no.
- 97167024
- Registration no.
- 7009804
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 4 classes
Who owns HYBRID CONCEPTS INTERNATIONAL
The owner and representative on file with the office.
Owner
Hybrid Concepts International, LLC
Grand Island, United States
Representative
John P. Murtaugh
Pearne & Gordon LLP
What the mark covers
The products and services HYBRID CONCEPTS INTERNATIONAL is filed for, grouped by Nice class.
Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics
Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
10 earlier steps on the official record.
About HYBRID CONCEPTS INTERNATIONAL
Who owns the trademark "HYBRID CONCEPTS INTERNATIONAL"?
The USPTO trademark "HYBRID CONCEPTS INTERNATIONAL" (application 97167024) is owned by Hybrid Concepts International, LLC.
What is the status of "HYBRID CONCEPTS INTERNATIONAL"?
Its status at the USPTO is: registered.
When was "HYBRID CONCEPTS INTERNATIONAL" registered?
It was registered on March 28, 2023.
Get this data via the API
Everything on this page comes from the Signa API. Pull HYBRID CONCEPTS INTERNATIONAL and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d29f6-86c6-7574-a31d-72309252e312
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d29f6-86c6-7574-a31d-72309252e312",
"object": "trademark",
"mark_text": "HYBRID CONCEPTS INTERNATIONAL",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97167024",
"filing_date": "2021-12-10",
"nice_classes": [
35,
36,
42,
44
],
"owners": [
{
"name": "HYBRID CONCEPTS INTERNATIONAL, LLC",
"entity_id": null
}
]
}